Page 299 - Read Online

Fung et al. Antivirals in hepatitis B hepatocellular carcinoma

adherent to the EASL/AASLD recommendations? An observational Oncol 2014;21:2429-35.
study of the HCC East-West study group. Ann Surg 2013;257:929-37. 48. Wu JC, Huang YH, Chau GY, Su CW, Lai CR, Lee PC, Huo TI, Sheen
33. Sasaki K, Shindoh J, Nishioka Y, Margonis GA, Sugawara T, IJ, Lee SD, Lui WY. Risk factors for early and late recurrence in
Andreatos N, Hashimoto M, Pawlik TM. Impact of viral etiology on hepatitis B-related hepatocellular carcinoma. J Hepatol 2009;51:890-
postoperative de novo recurrence after hepatectomy for hepatocellular 7.
carcinoma in cirrhotic patients. J Gastrointest Surg 2017;21:487-95. 49. Lee HW, Choi GH, Kim DY, Park YN, Kim KS, Choi JS, Ahn
34. Li Z, Zhao X, Jiang P, Xiao S, Wu G, Chen K, Zhang X, Liu H, Han SH, Han KH. Less fibrotic burden differently affects the long-
X, Wang S, Li X. HBV is a risk factor for poor patient prognosis after term outcomes of hepatocellular carcinoma after curative resection.
curative resection of hepatocellular carcinoma: a retrospective case- Oncology 2017;93:224-32.
control study. Medicine (Baltimore) 2016;95:e4224. 50. Wei Q, Tian H, Luo HX, Zhang YC, Deng YN, Yao J, Li H, Chen GH,
35. Chen X, Wu F, Liu Y, Lou J, Zhu B, Zou L, Chen W, Gong J, Wang Yang Y. Better prognosis of hepatic resection combined with antiviral
Y, Zhong R. The contribution of serum hepatitis B virus load in the therapy for HBV-related hepatocellular carcinoma with BCLC Stage
carcinogenesis and prognosis of hepatocellular carcinoma: evidence B/C. Asian J Surg 2017;40:453-62.
from two meta-analyses. Oncotarget 2016;7:49299-309. 51. Ho CM, Lee PH, Shau WY, Ho MC, Wu YM, Hu RH. Survival
36. Huang G, Lau WY, Shen F, Pan ZY, Fu SY, Yang Y, Zhou WP, in patients with recurrent hepatocellular carcinoma after primary
Wu MC. Preoperative hepatitis B virus DNA level is a risk factor hepatectomy: comparative effectiveness of treatment modalities.
for postoperative liver failure in patients who underwent partial Surgery 2012;151:700-9.
hepatectomy for hepatitis B-related hepatocellular carcinoma. World J 52. Lei Z, Li J, Wu D, Xia Y, Wang Q, Si A, Wang K, Wan X, Lau
Surg 2014;38:2370-6. WY, Wu M, Shen F. Nomogram for preoperative estimation of
37. Hung IF, Poon RT, Lai CL, Fung J, Fan ST, Yuen MF. Recurrence of microvascular invasion risk in hepatitis B virus-related hepatocellular
hepatitis B-related hepatocellular carcinoma is associated with high carcinoma within the milan criteria. JAMA Surg 2016;151:356-63.
viral load at the time of resection. Am J Gastroenterol 2008;103:1663- 53. Zhou HB, Li QM, Zhong ZR, Hu JY, Jiang XL, Wang H, Wang H,
73. Yang B, Hu HP. Level of hepatitis B surface antigen might serve as a
38. Wei X, Li N, Li S, Shi J, Guo W, Zheng Y, Cheng S. Hepatitis B virus new marker to predict hepatocellular carcinoma recurrence following
infection and active replication promote the formation of vascular curative resection in patients with low viral load. Am J Cancer Res
invasion in hepatocellular carcinoma. BMC Cancer 2017;17:304. 2015;5:756-71.
39. Lao XM, Luo G, Ye LT, Luo C, Shi M, Wang D, Guo R, Chen M, 54. Huang G, Lau WY, Zhou WP, Shen F, Pan ZY, Yuan SX, Wu MC.
Li S, Lin X, Yuan Y. Effects of antiviral therapy on hepatitis B virus Prediction of hepatocellular carcinoma recurrence in patients with low
reactivation and liver function after resection or chemoembolization hepatitis B virus DNA levels and high preoperative hepatitis B surface
for hepatocellular carcinoma. Liver Int 2013;33:595-604. antigen levels. JAMA Surg 2014;149:519-27.
40. Huang G, Lai EC, Lau WY, Zhou WP, Shen F, Pan ZY, Fu SY, 55. Hung IF, Wong DK, Poon RT, Fong DY, Chui AH, Seto WK, Fung
Wu MC. Posthepatectomy HBV reactivation in hepatitis B-related JY, Chan AC, Yuen JC, Tiu R, Choi O, Lai CL, Yuen MF. Risk
hepatocellular carcinoma influences postoperative survival in patients factors and post-resection independent predictive score for the
with preoperative low HBV-DNA levels. Ann Surg 2013;257:490-505. recurrence of hepatitis B-related hepatocellular carcinoma. PLoS One
41. Xie ZB, Zhu SL, Peng YC, Chen J, Wang XB, Ma L, Bai T, Xiang 2016;11:e0148493.
BD, Li LQ, Zhong JH. Postoperative hepatitis B virus reactivation 56. Yin J, Li N, Han Y, Xue J, Deng Y, Shi J, Guo W, Zhang H, Wang
and surgery-induced immunosuppression in patients with hepatitis H, Cheng S, Cao G. Effect of antiviral treatment with nucleotide/
B-related hepatocellular carcinoma. J Surg Oncol 2015;112:634-42. nucleoside analogs on postoperative prognosis of hepatitis B virus-
42. Qiao M, Gowans EJ, Burrell CJ. Intracellular factors, but not virus related hepatocellular carcinoma: a two-stage longitudinal clinical
receptor levels, influence the age-related outcome of DHBV infection study. J Clin Oncol 2013;31:3647-55.
of ducks. Virology 1992;186:517-23. 57. Wu CY, Chen YJ, Ho HJ, Hsu YC, Kuo KN, Wu MS, Lin JT.
43. Gong WF, Zhong JH, Lu SD, Wang XB, Zhang QM, Ma L, Association between nucleoside analogues and risk of hepatitis B
Zhang ZM, Xiang BD, Li LQ. Effects of antiviral therapy on post- virus-related hepatocellular carcinoma recurrence following liver
hepatectomy HBV reactivation and liver function in HBV DNA- resection. JAMA 2012;308:1906-14.
negative patients with HBV-related hepatocellular carcinoma. 58. Liu GM, Huang XY, Shen SL, Hu WJ, Peng BG. Adjuvant antiviral
Oncotarget 2017;8:15047-56. therapy for hepatitis B virus-related hepatocellular carcinoma after
44. Xie ZB, Wang XB, Fu DL, Zhong JH, Yang XW, Li LQ. Postoperative curative treatment: a systematic review and meta-analysis. Hepatol
hepatitis B virus reactivation in hepatitis B virus-related hepatocellular Res 2016;46:100-10.
carcinoma patients with hepatitis B virus DNA levels <500 copies/ 59. Huang G, Lau WY, Wang ZG, Pan ZY, Yuan SX, Shen F, Zhou WP,
mL. Onco Targets Ther 2016;9:4593-603. Wu MC. Antiviral therapy improves postoperative survival in patients
45. Lee JI, Kim JK, Chang HY, Lee JW, Kim JM, Chung HJ, Kim with hepatocellular carcinoma: a randomized controlled trial. Ann
YS, Lee KS. Impact of postoperative hepatitis B virus reactivation Surg 2015;261:56-66.
in hepatocellular carcinoma patients who formerly had naturally 60. Wong GL, Tse YK, Chan HL, Yip TC, Tsoi KK, Wong VW. Oral
suppressed virus. J Gastroenterol Hepatol 2014;29:1019-27. nucleos(t)ide analogues reduce recurrence and death in chronic
46. Sohn W, Paik YH, Cho JY, Ahn JM, Choi GS, Kim JM, Kwon CH, hepatitis B-related hepatocellular carcinoma. Aliment Pharmacol Ther
Joh JW, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, 2016;43:802-13.
Yoo BC. Influence of hepatitis B virus reactivation on the recurrence 61. Zhang H, Zhou Y, Yuan G, Zhou G, Yang D, Zhou Y. Antiviral therapy
of HBV-related hepatocellular carcinoma after curative resection in improves the survival rate and decreases recurrences and fatalities in
patients with low viral load. J Viral Hepat 2015;22:539-50. liver cancer patients following curative resection: a meta-analysis.
47. Sohn W, Paik YH, Kim JM, Kwon CH, Joh JW, Cho JY, Gwak Mol Clin Oncol 2015;3:1239-47.
GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. HBV DNA and 62. Zhou Y, Zhang Z, Zhao Y, Wu L, Li B. Antiviral therapy decreases
HBsAg levels as risk predictors of early and late recurrence after recurrence of hepatitis B virus-related hepatocellular carcinoma after
curative resection of HBV-related hepatocellular carcinoma. Ann Surg curative resection: a meta-analysis. World J Surg 2014;38:2395-402.

Hepatoma Research ¦ Volume 3 ¦ November 27, 2017 291